Profile
MLSS ISRG BDX BDXA ALC RMD
Company Name Milestone Scientific Inc. Intuitive Surgical, Inc. Becton, Dickinson and Company Becton, Dickinson and Company Alcon Inc. ResMed Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $59.64M $191.29B $49.98B $48.71B $43.43B $37.41B
Employees 0.02K 15.64K 70.00K 0.00K 25.60K 9.98K
CEO Neal Ira Goldman CFA Gary S. Guthart Mr. Thomas E. Polen Jr. - David J. Endicott Michael J. Farrell BE, MBA, SM
Ratings
MLSS ISRG BDX BDXA ALC RMD
Quant Rating Score 2 3 3 5 3 3
Quant Rating Sell Neutral Neutral Strong Buy Neutral Neutral
Trading
MLSS ISRG BDX BDXA ALC RMD
Last Close $0.727 $533.71 $170.86 $59.24 $87.81 $255.16
High 52 $1.33 $610.45 $249.08 $59.24 $100.76 $257.91
Low 52 $0.62 $416.14 $165.15 $59.24 $82.73 $186.94
Price vs. 52 Week High -45.34 % -12.57 % -31.4 % 0 % -12.85 % -1.07 %
Price vs. 52 Week Low 17.26 % 28.25 % 3.46 % 0 % 6.14 % 36.49 %
Total Return
MLSS ISRG BDX BDXA ALC RMD
1 Month Return -21.2 % -3.35 % -1 % 0 % 2.16 % 4.24 %
3 Month Return -26.57 % 8.51 % -24.9 % 0 % -8.31 % 16.01 %
6 Month Return -21.57 % 1.28 % -24.57 % 0 % 3.61 % 11.18 %
9 Month Return -20.15 % 8.64 % -29.13 % 0 % -12.25 % 4.52 %
YTD Return -24.27 % 2.25 % -24.69 % 0 % 3.44 % 11.57 %
1 Year Return 6.4 % 19.98 % -26.89 % 0 % -1.43 % 33.3 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
MLSS ISRG BDX BDXA ALC RMD
Dividend Yield Percentage (TTM) - - 2.33 % 2.38 % 0.38 % 0.83 %
Dividend Paid and Capex Coverage Ration (TTM) -267.77 % 2.77 % 1.77 % 1.77 % 4.15 % 4.21 %
Dividend Per Share (TTM) - - 4.07 % 4.07 % 0.33 % 2.12 %
Payout Ratio (TTM) - - 76.77 % 76.77 % 11.23 % 23.14 %
Growth
MLSS ISRG BDX BDXA ALC RMD
Asset Growth -13.85 % 8.54 % 8.54 % 2.48 %
Gross Profit Growth -5.27 % 11.69 % 11.69 % 5.05 %
Revenue Growth -12.19 % 4.16 % 4.16 % 4.82 %
Revenue 3 Year -27.76 % -0.51 % -0.51 % 18.48 %
Revenue 5 Year -40.93 % 8.72 % 8.72 % 30.35 %
Revenue 10 Year -79 % 59.37 % 59.37 % 50.3 %
EBIT Growth 4.92 % 19.82 % 19.82 % 41.82 %
Net Income Growth 31.97 % 14.89 % 14.89 % 4.52 %
Net Income 3 Yeari Growth Per Share 42.88 % -18.63 % -18.63 % 168.34 %
Net Income 5 Yeari Growth Per Share 64.73 % 30.19 % 30.19 % 253.24 %
Net Income 10 Yeari Growth Per Share 30.36 % -4.02 % -4.02 % 239.64 %
Operating Income Growth 4.92 % 13.55 % 13.55 % 36 %
Operating Cash Flow Growth (CFG) 45.18 % 27.07 % 27.07 % 49.64 %
Operating 3 Year CFG 37.31 % -18.4 % -18.4 % 53.05 %
Operating 5 Year CFG 5.93 % 6.25 % 6.25 % 122.93 %
Operating 10 Year CFG -294.78 % 45.28 % 45.28 % 55.79 %
EPS Growth 36.97 % 18.31 % 18.31 % 4.04 %
EPS Diluted Growth 36.97 % 18.62 % 18.62 % 4.59 %
Book Value Per Share -33.61 % -0.85 % -0.85 % 4.21 %
Share Holder 3 Year Equity Growth Per Share -69.26 % 9.16 % 9.16 % 10.93 %
Share Holder 5 Year Equity Growth Per Share 97.15 % 13.89 % 13.89 % 10.26 %
Share Holder 10 Year Equity Growth Per Share -89.99 % 241.78 % 241.78 % -9.87 %
Dividend Per Share Growth - -2.44 % -2.44 % 11.75 %
Dividend 3 Year Growth Per Share - 4.79 % 4.79 % 138.09 %
Dividend 5 Year Growth Per Share - 4.14 % 4.14 % -
Dividend 10 Year Growth Per Share - 74.3 % 74.3 % -
Debt Growth -11.85 % 26.65 % 26.65 % 0.02 %
Free Cash Flow Growth 45.04 % 45.25 % 45.25 % 162.01 %
Updated On 31 Dec 2024 30 Sep 2024 30 Sep 2024 31 Dec 2024
Profitability
MLSS ISRG BDX BDXA ALC RMD
Gross Profit Margin TTM 100.39 % 67.09 % 44.5 % 44.5 % 55.55 % 58.53 %
Return on Assets TTM -57.96 % 12.88 % 2.75 % 2.75 % 3.61 % 17.36 %
Return on Equity TTM -82.73 % 15.52 % 5.86 % 5.86 % 6.95 % 25.18 %
Return on Capital Employed TTM -156.96 % 13.9 % 5.05 % 5.05 % 5.26 % 24.33 %
Net Income Per EBT TTM 100 % 88.31 % 89.01 % 89.01 % 83.9 % 83.26 %
EBT Per Ebit TTM 72.26 % 114.09 % 71.19 % 71.19 % 88.24 % 97.84 %
EBIT Per Revenue TTM -114.24 % 28.2 % 11.33 % 11.33 % 15.22 % 32.1 %
Cash Flow To Debt Ratio TTM -850.29 % - 17.12 % 17.12 % 40.46 % 196.83 %
Receivables Turnover TTM 12.31 6.46 6.89 6.89 5.35 5.53
Payables Turnover TTM 0.85 10.39 - - 5.25 9.36
Inventory Turnover TTM 0.39 1.85 3.11 3.11 1.89 2.41
Fixed Asset Turnover TTM 2157.59 % 181.6 % 313.98 % 313.98 % 202.74 % 729.93 %
Asset Turnover TTM 70.21 % 45.34 % 38.31 % 38.31 % 32.06 % 66.36 %
Operating Cash Flow Per Share TTM -0.03 7.64 11.44 11.44 4.24 11.27
Free Cash Flow Per Share TTM -0.03 4.88 8.98 8.98 3.47 10.66
Cash Per Share TTM 2.82 % 1261.9 % 236.81 % 236.81 % 285.19 % 635.71 %
Operating Cash Flow Sales Ratio TTM -42.47 % 31.34 % 15.81 % 15.81 % 21.14 % 32.92 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.13 % 63.9 % 78.51 % 78.51 % 81.86 % 94.64 %
Cash Flow Coverage Ratios TTM -850.29 % - 17.12 % 17.12 % 40.46 % 196.83 %
Price To Free Cash Flows Ratio TTM -21.98 109.6 19.3 18.91 25.25 23.92
Price To Operating Cash Flows Ratio TTM -22.38 69.86 15.25 14.94 20.69 22.65
Price Cash Flow Ratio TTM -22.38 69.86 15.25 14.94 20.69 22.65
Income Statement (TTM)
MLSS ISRG BDX BDXA ALC RMD
Revenue $0.01B $8.35B $20.18B $20.18B $9.91B $4.69B
Gross Profit $0.01B $5.63B $9.13B $9.13B $5.51B $2.66B
Gross Profit Ratio 74.56% 67.46% 45.22% 45.22% 55.61% 56.67%
EBITDA $-0.01B $2.81B $4.82B $4.82B $2.68B $1.53B
Net Income $-0B $2.32B $1.71B $1.71B $1.02B $1.02B
EPS Diluted -0.06 6.42 5.86 5.86 2.05 6.92
Balance Sheet (MRQ)
MLSS ISRG BDX BDXA ALC RMD
Long Term Debt $0B $0.11B $17.94B $17.94B $4.97B $0.84B
Total Liabilities $0B $2.21B $31.4B $31.4B $8.79B $2.01B
Total Equity $0.01B $16.53B $25.89B $25.89B $21.55B $4.86B
Total Investments $0B $6.89B $0.45B $0.45B $0.75B $0.17B
Total Debt $0B $0.15B $20.11B $20.11B $5.14B $0.87B
Total Assets $0.01B $18.74B $57.29B $57.29B $30.35B $6.87B
Cash Flow Statement (TTM)
MLSS ISRG BDX BDXA ALC RMD
Net Income $-0B $2.34B $1.71B $1.71B $1.02B $1.02B
Inventory $-0B $-0.83B $0.1B $0.1B $-0.05B $0.17B
Dividends Paid $0B $0B $-1.1B $-1.1B $-0.13B $-0.28B
Operating Cash Flow $-0B $2.42B $3.8B $3.8B $2.08B $1.4B
Capital Expenditure $-0B $-1.11B $-0.73B $-0.73B $-0.67B $-0.11B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.34
ALC Alcon Inc. 88.3
ANGO AngioDynamics, Inc. 9.92
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 156.42
ATRC AtriCure, Inc. 32.795
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AZTA Azenta, Inc. 30.77
BAX Baxter International Inc. 30.285
BDX Becton, Dickinson and Company 172.245
BDXA Becton, Dickinson and Company 59.24
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 13.015
BLFS BioLife Solutions, Inc. 21.55
COO The Cooper Companies, Inc. 71.28
DXR Daxor Corporation 9.79
EKSO Ekso Bionics Holdings, Inc. 3.28
FEMY Femasys Inc. 0.9662
ETFs With Exposure to MLSS
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 304.09
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00002 135.09
VXF Vanguard Extended Market Index Fund 0 192.88
IWC iShares Micro-Cap ETF 0.00043 127.885
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 103.17
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 103.15
VTSAX Vanguard Total Stock Market Index Fund 0 147.67
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 145.5
VITSX Vanguard Total Stock Market Index Fund 0 147.69
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000107228 104.16
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 145.51
VEMPX Vanguard Extended Market Index InstlPlus 0 359.07
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 277.06
Unlock